A regional initiative of Bangladesh, India and Nepal, launched in 2005 with World Health Organization South-East Asia Regional Office support, to eliminate kala-azar, or visceral leishmaniasis, as a public health problem. At the time the WHO South-East Asia Region carried about 70 percent of the world's kala-azar burden, and the three governments set an elimination threshold of fewer than one case per 10,000 people at the district level in Nepal and the subdistrict level in Bangladesh and India. Reported cases fell from roughly 182,000 during 2005-2008 to about 85,000 during 2011-2014, a decline WHO credits to expanded vector control, improved diagnosis and case management under the initiative, and the three countries carried the effort into a further phase covering 2022 to 2026 aimed at validating elimination of the disease as a public health problem across the region.
Facts
Sponsoring BodyWorld Health Organization South-East Asia Regional Office, with the governments of Bangladesh, India and Nepal 1 Health GoalEliminate visceral leishmaniasis (kala-azar) as a public health problem, reducing incidence to less than one case per 10,000 population at sub-district level 1 Classification
Program Kind Connections
Delivers Practice
Entity-backed identity for the program-kind enum value this public health program already carries, resolved to a health practice by an explicit value-to-entity map (phase 3 bucket conversion, docs\design_entity_backed_browse_buckets_20260928.md). The program-kind fact itself stays on the program unchanged.
Sources
1. WHO: South-East Asia Poised to Defeat Visceral Leishmaniasis (Kala-azar)
World Health Organization, 2015Elimination target paragraph, WHO kala-azar news item
less than one case per 10 000 population
Program classification, entity description sentence
Reported cases fell from roughly 182,000 during 2005-2008 to about 85,000 during 2011-2014, a decline WHO credits to expanded vector control, improved diagnosis and case management under the initiative, and the three countries carried the effort into a further phase covering 2022 to 2026 aimed at validating elimination of the disease as a public health problem across the region.
View the Source Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.